<qa>  What STUDY OF TARCEVA is ERLOTINIB?ASPET STUDY: AN OBSERVATIONAL STUDY OF TARCEVA ERLOTINIB IN FIRST LINE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBOURING EGFR ACTIVATING MUTATIONS: 